Details for Patent: 8,765,150
✉ Email this page to a colleague
Which drugs does patent 8,765,150 protect, and when does it expire?
Patent 8,765,150 protects TIGLUTIK KIT and is included in one NDA.
This patent has twenty-five patent family members in twenty-one countries.
Summary for Patent: 8,765,150
| Title: | Riluzole aqueous suspensions |
| Abstract: | Physically and chemically stable aqueous oral suspensions of riluzole and manufacturing methods thereof. The suspensions contain riluzole in particle form and at least a wetting agent, preferably a surfactant. Riluzole is present in amounts from about 0.1% to about 20% w/v and has an average particle size lower than 200 .mu.m. The suspensions are devoid of the known local (mouth) anaesthetic effects of riluzole. |
| Inventor(s): | Artico; Roberta (Milan, IT), Adami; Marco (Milan, IT), Barbareschi; Daniele (Milan, IT), Moscoso; Jaime (Alcoendas, ES), Oldoni; Tiziano (Milan, IT), Mascagni; Paolo (Milan, IT) |
| Assignee: | Italfarmaco SpA (Milan, IT) |
| Application Number: | 13/138,047 |
|
Patent Claim Types: see list of patent claims | Use; Compound; |
Drugs Protected by US Patent 8,765,150
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Italfarmaco Sa | TIGLUTIK KIT | riluzole | SUSPENSION;ORAL | 209080-001 | Sep 5, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | A METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS IN A PATIENT IN NEED OF SUCH TREATMENT, SAID METHOD COMPRISING ADMINISTERING TO SAID PATIENT AN EFFECTIVE AMOUNT OF A SUSPENSION ACCORDING TO CLAIM 1 | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,765,150
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 09425101 | Mar 13, 2009 | |
| PCT Information | |||
| PCT Filed | March 02, 2010 | PCT Application Number: | PCT/EP2010/052598 |
| PCT Publication Date: | September 16, 2010 | PCT Publication Number: | WO2010/102923 |
International Family Members for US Patent 8,765,150
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Brazil | PI1006418 | ⤷ Try a Trial | |||
| Canada | 2748856 | ⤷ Try a Trial | |||
| Chile | 2011002217 | ⤷ Try a Trial | |||
| China | 102341091 | ⤷ Try a Trial | |||
| Colombia | 6410281 | ⤷ Try a Trial | |||
| Cyprus | 1113825 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
